Vitruvias Therapeutics, Inc. — Form D/A
Vitruvias Therapeutics, Inc. of AUBURN, AL, a company, filed a Form D amendment with the SEC on 2018-01-05. The offering totals $11.5M, of which $11.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-01-05
- Form: D/A
- Accession: 0001592342-18-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $11.5M
- Amount sold: $11.5M
- Minimum investment: $25K
- Investors: 23
- Date of first sale: 2017-12-26
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-301275
Issuer
- Name: Vitruvias Therapeutics, Inc.
- CIK: 0001592342
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 670 NORTH COLLEGE STREET, AUBURN, AL, 36830
- Phone: 334-329-5601
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Michael D Altman | Director | New York, NY |
| Bryce M Harvey | Director | Santa Rosa Beach, FL |
| Edward D Schutter | Director | Marietta, GA |
| Carl L Whatley | Director | Auburn, AL |
| Jason D Wild | Director | New York, NY |
| Roger D Graben | Executive Officer | Auburn, AL |
| Bryce M Harvey | Executive Officer | Santa Rosa Beach, FL |
| Carl L Whatley | Executive Officer | Auburn, AL |
| Roger D Graben | Director | Auburn, AL |
| A Stuart Hendon | Director | Montgomery, AL |
| Charles T Smith | Director | Florala, AL |
| Thomas A Main | Director | Union Springs, AL |
| Carl Leo Whatley, Jr. | Executive Officer | Montgomery, AL |
Other filings by this issuer (4)
More